Shafer Width and Girth: The Use of Injectable Fillers for Penile Enhancement

Last updated: May 20, 2026
Sponsor: Shafer Clinic Fifth Avenue
Overall Status: Completed

Phase

N/A

Condition

Male Hormonal Deficiencies/abnormalities

Treatment

Hyaluronic Acid

Clinical Study ID

NCT04755634
Pro00034295
  • Ages 21-65
  • Male
  • Accepts Healthy Volunteers

Study Summary

Injectable filler will be performed by Principal Investigator under sterile conditions for the enhancement of girth and surface area of the penis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Healthy males,

  • 21 to 65 years of age,

  • Seeking enhancement of their penile width and girth.

Exclusion

Exclusion Criteria:

  • Patient with a history of psychological or psychiatric illness,

  • Congenital or acquired penile malformation,

  • Previous plastic surgery or non-invasive treatments of their penis,

  • Any chronic disease such as vascular disorder, urological disorder, myocardialinfarction, hypertension, cerebrovascular accident or coagulopathy.

  • Patients with a history of allergic reactions to hyaluronic acid derivatives

  • Individuals with penises measured less than 6 cm in length in the flaccid position

  • Individuals with penises greater than 12.5 cm in length in the flaccid position.

  • Individuals with uncircumcised penises

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Hyaluronic Acid
Phase:
Study Start date:
April 23, 2021
Estimated Completion Date:
June 27, 2024

Connect with a study center

  • Shafer Clinic Fifth Avenue

    New York, New York 10017
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.